Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (HIIP)

NCT00099515 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: LY041001 (HIIP)
DRUG: LY041001 (HIIP)

Sponsor

Eli Lilly and Company

Collaborators

[object Object]